Medical device industry trade group AdvaMed spent $2.1m on lobbying the US Congress in the first quarter of 2020, more than twice what it spent – $1m – in the first quarter of 2019.
Overall, AdvaMed paid out $5.6m for US lobbying activities throughout 2019, according to a compilation of lobbying reports required to be filed each quarter with the Senate Office of Policy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?